Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implementation and physician behavior change : an industry perspective.

G S Tillotson1

  • 1International Scientific Relations, Bayer Corporation, West Haven, CT 06516, USA. glenn.tillotson.b@bayer.com

Chest
|August 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antimicrobial resistance--fluoroquinolones and the tiger's tail.

Journal of chemotherapy (Florence, Italy)·2006
Same author

Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004).

International journal of antimicrobial agents·2006
Same author

Adverse cutaneous reactions and drugs: a focus on antimicrobials.

Journal of chemotherapy (Florence, Italy)·2006
Same author

Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC.

Journal of chemotherapy (Florence, Italy)·2004
Same author

Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.

International journal of antimicrobial agents·2004
Same author

Respiratory fluoroquinolones: differences in the details.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2004
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
See all related articles

Clinical practice guidelines (CPGs) are numerous but their real-world use is inconsistent. Increased pharmaceutical industry involvement in CPG development could improve patient care and guideline applicability.

Area of Science:

  • Health Services Research
  • Medical Guidelines
  • Pharmaceutical Industry

Background:

  • Clinical practice guidelines (CPGs) are increasingly prevalent but their practical utility and application face scrutiny.
  • Significant resources are invested in guideline creation, yet dissemination to end-users varies widely.

Purpose of the Study:

  • To explore the variable utility and applicability of clinical practice guidelines.
  • To investigate the potential role of the pharmaceutical industry in enhancing guideline development and dissemination.

Main Methods:

  • This study is a conceptual analysis and discussion piece.
  • It examines the current landscape of clinical practice guideline development and implementation.

Main Results:

Related Experiment Videos

  • The effectiveness and reach of clinical practice guidelines are inconsistent.
  • The pharmaceutical industry possesses resources that could aid guideline dissemination and application.

Conclusions:

  • Greater involvement of the pharmaceutical industry in clinical practice guideline development is essential.
  • Overcoming mutual apprehension between guideline developers and industry is crucial for improving healthcare through better patient management.